Matthew D Snape1,2, Russell M Viner3. 1. Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. matthew.snape@paediatrics.ox.ac.uk r.viner@ucl.ac.uk. 2. National Institute for Health Research (NIHR), Oxford Biomedical Research Centre, Oxford, UK. 3. Great Ormond Street Institute for Child Health, University College London, London, UK. matthew.snape@paediatrics.ox.ac.uk r.viner@ucl.ac.uk.
Authors: Julian W Tang; Miguela A Caniza; Mike Dinn; Dominic E Dwyer; Jean-Michel Heraud; Lance C Jennings; Jen Kok; Kin On Kwok; Yuguo Li; Tze Ping Loh; Linsey C Marr; Eva Megumi Nara; Nelun Perera; Reiko Saito; Carlos Santillan-Salas; Sheena Sullivan; Matt Warner; Aripuanã Watanabe; Sabeen Khurshid Zaidi Journal: Interface Focus Date: 2022-02-11 Impact factor: 3.906
Authors: Anna A Mensah; Mary Sinnathamby; Asad Zaidi; Laura Coughlan; Ruth Simmons; Sharif A Ismail; Mary E Ramsay; Vanessa Saliba; Shamez N Ladhani Journal: J Infect Date: 2021-02-25 Impact factor: 6.072
Authors: Franziska Hommes; Welmoed van Loon; Marlene Thielecke; Igor Abramovich; Sascha Lieber; Ralf Hammerich; Sabine Gehrke-Beck; Elisabeth Linzbach; Angela Schuster; Katja von dem Busche; Stefanie Theuring; Maximilian Gertler; Gabriela Equihua Martinez; Joachim Richter; Clara Bergmann; Alisa Bölke; Falko Böhringer; Marcus A Mall; Alexander Rosen; Alexander Krannich; Jan Keller; Norma Bethke; Marco Kurzmann; Tobias Kurth; Valerie Kirchberger; Joachim Seybold; Frank P Mockenhaupt; Becoss Study Group Journal: Int J Environ Res Public Health Date: 2021-03-08 Impact factor: 3.390